Medical Devices & Consumables

Global Fragile X Syndrome Testing Market Research Report 2026

This report delivers a comprehensive overview of the global Fragile X Syndrome Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Fragile X Syndrome Testing. The Fragile X Syndrome Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Fragile X Syndrome Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Fragile X Syndrome Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bio-Techne
Thermo Fisher Scientific
Blackhills Diagnostic Resources (BDR)
Mylab Discovery Solutions
Diagnostica Longwood
Microread Genetics
Segment by Type
Carrier Testing
Diagnostic Testing
Segment by Application
Hospital
Lab
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Fragile X Syndrome Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragile X Syndrome Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.3 Market by Application
1.3.1 Global Fragile X Syndrome Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Lab
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fragile X Syndrome Testing Market Perspective (2021–2032)
2.2 Global Fragile X Syndrome Testing Growth Trends by Region
2.2.1 Global Fragile X Syndrome Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Fragile X Syndrome Testing Historic Market Size by Region (2021–2026)
2.2.3 Fragile X Syndrome Testing Forecasted Market Size by Region (2027–2032)
2.3 Fragile X Syndrome Testing Market Dynamics
2.3.1 Fragile X Syndrome Testing Industry Trends
2.3.2 Fragile X Syndrome Testing Market Drivers
2.3.3 Fragile X Syndrome Testing Market Challenges
2.3.4 Fragile X Syndrome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragile X Syndrome Testing Players by Revenue
3.1.1 Global Top Fragile X Syndrome Testing Players by Revenue (2021–2026)
3.1.2 Global Fragile X Syndrome Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Fragile X Syndrome Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Fragile X Syndrome Testing Revenue
3.4 Global Fragile X Syndrome Testing Market Concentration Ratio
3.4.1 Global Fragile X Syndrome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragile X Syndrome Testing Revenue in 2025
3.5 Global Key Players of Fragile X Syndrome Testing Head Offices and Areas Served
3.6 Global Key Players of Fragile X Syndrome Testing, Products and Applications
3.7 Global Key Players of Fragile X Syndrome Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Fragile X Syndrome Testing Breakdown Data by Type
4.1 Global Fragile X Syndrome Testing Historic Market Size by Type (2021–2026)
4.2 Global Fragile X Syndrome Testing Forecasted Market Size by Type (2027–2032)
5 Fragile X Syndrome Testing Breakdown Data by Application
5.1 Global Fragile X Syndrome Testing Historic Market Size by Application (2021–2026)
5.2 Global Fragile X Syndrome Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Fragile X Syndrome Testing Market Size (2021–2032)
6.2 North America Fragile X Syndrome Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Fragile X Syndrome Testing Market Size by Country (2021–2026)
6.4 North America Fragile X Syndrome Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fragile X Syndrome Testing Market Size (2021–2032)
7.2 Europe Fragile X Syndrome Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Fragile X Syndrome Testing Market Size by Country (2021–2026)
7.4 Europe Fragile X Syndrome Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Fragile X Syndrome Testing Market Size (2021–2032)
8.2 Asia-Pacific Fragile X Syndrome Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Fragile X Syndrome Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Fragile X Syndrome Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Fragile X Syndrome Testing Market Size (2021–2032)
9.2 Latin America Fragile X Syndrome Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Fragile X Syndrome Testing Market Size by Country (2021–2026)
9.4 Latin America Fragile X Syndrome Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragile X Syndrome Testing Market Size (2021–2032)
10.2 Middle East & Africa Fragile X Syndrome Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Fragile X Syndrome Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Fragile X Syndrome Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Details
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Fragile X Syndrome Testing Introduction
11.1.4 Bio-Techne Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.1.5 Bio-Techne Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Fragile X Syndrome Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Blackhills Diagnostic Resources (BDR)
11.3.1 Blackhills Diagnostic Resources (BDR) Company Details
11.3.2 Blackhills Diagnostic Resources (BDR) Business Overview
11.3.3 Blackhills Diagnostic Resources (BDR) Fragile X Syndrome Testing Introduction
11.3.4 Blackhills Diagnostic Resources (BDR) Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.3.5 Blackhills Diagnostic Resources (BDR) Recent Development
11.4 Mylab Discovery Solutions
11.4.1 Mylab Discovery Solutions Company Details
11.4.2 Mylab Discovery Solutions Business Overview
11.4.3 Mylab Discovery Solutions Fragile X Syndrome Testing Introduction
11.4.4 Mylab Discovery Solutions Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.4.5 Mylab Discovery Solutions Recent Development
11.5 Diagnostica Longwood
11.5.1 Diagnostica Longwood Company Details
11.5.2 Diagnostica Longwood Business Overview
11.5.3 Diagnostica Longwood Fragile X Syndrome Testing Introduction
11.5.4 Diagnostica Longwood Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.5.5 Diagnostica Longwood Recent Development
11.6 Microread Genetics
11.6.1 Microread Genetics Company Details
11.6.2 Microread Genetics Business Overview
11.6.3 Microread Genetics Fragile X Syndrome Testing Introduction
11.6.4 Microread Genetics Revenue in Fragile X Syndrome Testing Business (2021–2026)
11.6.5 Microread Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Fragile X Syndrome Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Global Fragile X Syndrome Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Fragile X Syndrome Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Fragile X Syndrome Testing Market Size by Region (US$ Million), 2021–2026
Table 7. Global Fragile X Syndrome Testing Market Share by Region (2021–2026)
Table 8. Global Fragile X Syndrome Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Fragile X Syndrome Testing Market Share by Region (2027–2032)
Table 10. Fragile X Syndrome Testing Market Trends
Table 11. Fragile X Syndrome Testing Market Drivers
Table 12. Fragile X Syndrome Testing Market Challenges
Table 13. Fragile X Syndrome Testing Market Restraints
Table 14. Global Fragile X Syndrome Testing Revenue by Players (US$ Million), 2021–2026
Table 15. Global Fragile X Syndrome Testing Market Share by Players (2021–2026)
Table 16. Global Top Fragile X Syndrome Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Fragile X Syndrome Testing Revenue, 2025
Table 17. Ranking of Global Top Fragile X Syndrome Testing Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Fragile X Syndrome Testing Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Fragile X Syndrome Testing, Headquarters and Area Served
Table 20. Global Key Players of Fragile X Syndrome Testing, Products and Applications
Table 21. Global Key Players of Fragile X Syndrome Testing, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Fragile X Syndrome Testing Market Size by Type (US$ Million), 2021–2026
Table 24. Global Fragile X Syndrome Testing Revenue Market Share by Type (2021–2026)
Table 25. Global Fragile X Syndrome Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Fragile X Syndrome Testing Revenue Market Share by Type (2027–2032)
Table 27. Global Fragile X Syndrome Testing Market Size by Application (US$ Million), 2021–2026
Table 28. Global Fragile X Syndrome Testing Revenue Market Share by Application (2021–2026)
Table 29. Global Fragile X Syndrome Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Fragile X Syndrome Testing Revenue Market Share by Application (2027–2032)
Table 31. North America Fragile X Syndrome Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Fragile X Syndrome Testing Market Size by Country (US$ Million), 2021–2026
Table 33. North America Fragile X Syndrome Testing Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Fragile X Syndrome Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Fragile X Syndrome Testing Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Fragile X Syndrome Testing Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Fragile X Syndrome Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Fragile X Syndrome Testing Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Fragile X Syndrome Testing Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Fragile X Syndrome Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Fragile X Syndrome Testing Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Fragile X Syndrome Testing Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Fragile X Syndrome Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Fragile X Syndrome Testing Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Fragile X Syndrome Testing Market Size by Country (US$ Million), 2027–2032
Table 46. Bio-Techne Company Details
Table 47. Bio-Techne Business Overview
Table 48. Bio-Techne Fragile X Syndrome Testing Product
Table 49. Bio-Techne Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 50. Bio-Techne Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Fragile X Syndrome Testing Product
Table 54. Thermo Fisher Scientific Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Blackhills Diagnostic Resources (BDR) Company Details
Table 57. Blackhills Diagnostic Resources (BDR) Business Overview
Table 58. Blackhills Diagnostic Resources (BDR) Fragile X Syndrome Testing Product
Table 59. Blackhills Diagnostic Resources (BDR) Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 60. Blackhills Diagnostic Resources (BDR) Recent Development
Table 61. Mylab Discovery Solutions Company Details
Table 62. Mylab Discovery Solutions Business Overview
Table 63. Mylab Discovery Solutions Fragile X Syndrome Testing Product
Table 64. Mylab Discovery Solutions Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 65. Mylab Discovery Solutions Recent Development
Table 66. Diagnostica Longwood Company Details
Table 67. Diagnostica Longwood Business Overview
Table 68. Diagnostica Longwood Fragile X Syndrome Testing Product
Table 69. Diagnostica Longwood Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 70. Diagnostica Longwood Recent Development
Table 71. Microread Genetics Company Details
Table 72. Microread Genetics Business Overview
Table 73. Microread Genetics Fragile X Syndrome Testing Product
Table 74. Microread Genetics Revenue in Fragile X Syndrome Testing Business (US$ Million), 2021–2026
Table 75. Microread Genetics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report


List of Figures
Figure 1. Fragile X Syndrome Testing Picture
Figure 2. Global Fragile X Syndrome Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Fragile X Syndrome Testing Market Share by Type: 2025 vs 2032
Figure 4. Carrier Testing Features
Figure 5. Diagnostic Testing Features
Figure 6. Global Fragile X Syndrome Testing Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Fragile X Syndrome Testing Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Lab Case Studies
Figure 10. Fragile X Syndrome Testing Report Years Considered
Figure 11. Global Fragile X Syndrome Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Fragile X Syndrome Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Fragile X Syndrome Testing Market Share by Region: 2025 vs 2032
Figure 14. Global Fragile X Syndrome Testing Market Share by Players in 2025
Figure 15. Global Fragile X Syndrome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Fragile X Syndrome Testing Revenue in 2025
Figure 17. North America Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Fragile X Syndrome Testing Market Share by Country (2021–2032)
Figure 19. United States Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Fragile X Syndrome Testing Market Share by Country (2021–2032)
Figure 23. Germany Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Fragile X Syndrome Testing Market Share by Region (2021–2032)
Figure 31. China Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Fragile X Syndrome Testing Market Share by Country (2021–2032)
Figure 39. Mexico Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Fragile X Syndrome Testing Market Share by Country (2021–2032)
Figure 43. Israel Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Fragile X Syndrome Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Bio-Techne Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 48. Blackhills Diagnostic Resources (BDR) Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 49. Mylab Discovery Solutions Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 50. Diagnostica Longwood Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 51. Microread Genetics Revenue Growth Rate in Fragile X Syndrome Testing Business (2021–2026)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies